MX2015003937A - Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. - Google Patents

Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.

Info

Publication number
MX2015003937A
MX2015003937A MX2015003937A MX2015003937A MX2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A MX 2015003937 A MX2015003937 A MX 2015003937A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
inflammatory
antihistaminic
composition including
immunosuppressant
Prior art date
Application number
MX2015003937A
Other languages
Spanish (es)
Inventor
Pablo Senosiain Pelaéz Juan
Angélica Arzola Paniagua Maria
Original Assignee
Alparis Sa De Cv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alparis Sa De Cv filed Critical Alparis Sa De Cv
Priority to MX2015003937A priority Critical patent/MX2015003937A/en
Priority to BR102016006254A priority patent/BR102016006254A2/en
Publication of MX2015003937A publication Critical patent/MX2015003937A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a pharmaceutical composition that contains an antihistaminic, anti-inflammatory glucocorticoid and pharmaceutically acceptable excipients or vehicles or a combination of an antihistaminic, anti-inflammatory-glucocorticoid, decongestant and pharmaceutically acceptable excipients or vehicles. The invention also refers to the use of said combination indicated for treating symptoms of nasal congestion, allergic and vasomotor rhinitis, acute rhinopharyngitis, asthma, hives and eyes and nose itching and a process for manufacturing said composition.
MX2015003937A 2015-03-26 2015-03-26 Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant. MX2015003937A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2015003937A MX2015003937A (en) 2015-03-26 2015-03-26 Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.
BR102016006254A BR102016006254A2 (en) 2015-03-26 2016-03-22 pharmaceutical combination of non-sedative antihistamine and anti-inflammatory immunosuppressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015003937A MX2015003937A (en) 2015-03-26 2015-03-26 Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.

Publications (1)

Publication Number Publication Date
MX2015003937A true MX2015003937A (en) 2016-09-26

Family

ID=57003228

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015003937A MX2015003937A (en) 2015-03-26 2015-03-26 Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.

Country Status (2)

Country Link
BR (1) BR102016006254A2 (en)
MX (1) MX2015003937A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023463A1 (en) * 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022023463A1 (en) * 2020-07-30 2022-02-03 Faes Farma, S.A. Decongestant drug delivery system

Also Published As

Publication number Publication date
BR102016006254A2 (en) 2016-09-27

Similar Documents

Publication Publication Date Title
MX2018013472A (en) Combination treatment of ocular inflammatory disorders and diseases.
SV2018005612A (en) AGENTS, USES AND METHODS FOR THE TREATMENT OF SINUCLEINOPATIA
EP3377050A4 (en) Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
CL2019001293A1 (en) Agents, uses and methods for the treatment of synucleinopathy.
PH12016501355A1 (en) Bicyclic heterocyclic derivatives as bromodomain inhibitors
WO2014064410A3 (en) Pharmaceutical composition comprising tiotropium and a hydrofluoroalkane
WO2016005466A3 (en) IMPROVED Aß PROTOFIBRIL BINDING ANTIBODIES
MX2017002374A (en) Compositions and methods to treat vision disorders.
CU20190060A7 (en) FORMS OF PHARMACEUTICAL ADMINISTRATION CONTAINING INHIBITORS OF TASK-1 AND TASK-3 CHANNELS HELPFUL IN THE TREATMENT OF RESPIRATORY DISORDERS
NZ705539A (en) Treatment of post-traumatic stress disorder with isolated mycobacterium
MX2020012979A (en) Methods for increasing sepiapterin plasma exposure.
CL2015000559A1 (en) Compounds derived from 2-oxo-2,3-dihydro-indoles; its process of obtaining; pharmaceutical composition and combination that includes them; and its use for the treatment of CNS disorders that are positive or negative symptoms of schizophrenia, substance abuse, alcohol and drug addiction, Alzheimer's disease, Parkinson's disease, among others.
NZ744323A (en) Compositions comprising 15-hepe and methods of using the same
IL286268A (en) Pridopidine for use in the treatment of mitochondrial associated diseases and disorders, including symptoms thereof
MX2019006495A (en) Treatment of neurological diseases.
EP3678671A4 (en) Methods for treating sleep disorders, sleep disturbances, and related symptoms using aminosterol compositions
ZA202212128B (en) Combination of alcaftadine and a corticosteroid
MX2021003862A (en) Crystalline forms and processes of lenvatinib besylate.
CO2020002992A2 (en) Pharmaceutical compositions containing anti-beta-amyloid antibodies
ZA201907101B (en) Methods of preventing or treating ophthalmic diseases
MX2015003937A (en) Pharmaceutical composition including a non-sedating antihistaminic and an anti-inflammatory immunosuppressant.
CL2023002871A1 (en) Nasal compositions comprising alcaftadine
EP3639854A4 (en) Mtor-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
WO2018098292A3 (en) Methods for treating opioid addiction
WO2017142895A8 (en) Compositions and methods for treating clostridium associated diseases